3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HF and CKD. ... in HF and CKD. ... in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
and recommended therapy ... angiotensin-receptor blocker; CAD ... resynchronization therapy ... ejection fraction; GDMT ... #CHF #Congestive
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed Medical Therapy ... and CKD • Class ... diuretics, MRA, SGLT2i ... Directed #Medical #Therapy ... #GDMT #CKD #HFrEF